How Ketamine Therapy Can Expand Clinical Practice

Mental health care continues to evolve as clinicians explore new ways to support people who have not found enough relief through traditional approaches. For professionals considering this area, ketamine therapy for clinicians can provide an opportunity to develop knowledge around an emerging treatment model while keeping psychotherapy, patient safety, and clinical judgment at the center.

Ketamine has been used medically for decades, primarily as an anesthetic. More recently, its potential role in mental health care has received considerable attention. It is important, however, to distinguish approved uses of ketamine and esketamine from off-label psychiatric use. The FDA notes that ketamine itself is not FDA-approved for the treatment of psychiatric disorders, while intranasal esketamine has specific FDA-approved uses and safety requirements.

Why Clinicians Are Exploring Ketamine-Based Care

The growing interest in ketamine-based mental health services is partly connected to research into rapid changes in depressive symptoms and other psychiatric conditions. Research has also examined how psychotherapy may be combined with ketamine treatment.

A 2023 systematic review found that studies combining ketamine and psychotherapy generally reported promising outcomes, but differences in treatment methods, psychotherapy approaches, and ketamine protocols made it difficult to establish one standard model.

For clinicians, this means education is particularly important. The goal is not simply to add another treatment to a service list. It is to understand where this approach may fit within a broader clinical framework.

How It Can Expand a Clinician's Practice

Adding knowledge of ketamine-based care can influence clinical practice in several practical ways.

1. Broader treatment conversations

Clinicians who understand the basics can have more informed conversations with patients who ask about emerging treatment options. This includes discussing potential benefits, limitations, risks, and the current state of evidence.

Such conversations can also help patients develop realistic expectations rather than viewing ketamine as a quick or universal solution.

2. Greater focus on preparation and integration

Psychotherapy remains an important consideration when ketamine and psychological treatment are combined. Published research has examined therapy before, during, and after ketamine sessions, although approaches vary considerably across studies.

This creates room for clinicians to strengthen skills such as:

• Establishing clear treatment goals

• Preparing patients for possible experiences

• Supporting emotional processing

• Helping patients reflect on experiences afterward

• Monitoring progress over time

• Maintaining appropriate therapeutic boundaries

These skills can complement existing psychotherapy experience rather than replace it.

3. Collaboration across disciplines

Ketamine-related care may involve more than one professional role. Depending on the treatment model and local requirements, medical professionals may oversee medication-related decisions while therapists focus on psychotherapy and patient support.

Understanding how these roles connect can help clinicians communicate more effectively with prescribers and other members of a treatment team.

4. Stronger attention to safety

Clinical expansion should always include a clear understanding of safety responsibilities. Ketamine can produce effects such as sedation, dissociation, and changes in blood pressure. The FDA has also warned about risks associated with compounded ketamine products used for psychiatric purposes.

Clinicians therefore need to understand their scope of practice, applicable regulations, screening procedures, emergency protocols, referral needs, and documentation responsibilities.

What Training Should Cover

Good education should go beyond explaining what ketamine is. Clinicians need practical knowledge that can translate into responsible patient care.

A useful training program may address:

• The history and pharmacology of ketamine

• Current research and limitations of the evidence

• Patient preparation

• Therapeutic approaches and communication

• Integration following treatment

• Safety and risk considerations

• Ethical and professional boundaries

• Collaboration with medical providers

• Legal and regulatory considerations

The evidence base is still developing. A 2026 systematic review of ketamine-assisted psychotherapy for treatment-resistant depression found encouraging findings in some studies, while also noting substantial variation in treatment methods and a need for stronger controlled research.

That makes ongoing learning especially valuable for clinicians entering this field.

Where Ketamine-Assisted Psychotherapy Fits

Ketamine-Assisted Psychotherapy generally refers to approaches that combine ketamine treatment with psychotherapy. The exact structure can differ between practices and may include therapeutic work before, during, or after medication administration.

Current research does not yet establish one universally accepted protocol. A 2026 systematic review noted that studies have used a wide range of psychotherapeutic approaches and treatment designs, reinforcing the need for further research and standardized methods.

For clinicians, this is an important point. Training should encourage careful assessment and evidence-informed practice rather than treating one protocol as appropriate for every patient.

Frequently Asked Questions 

Is ketamine FDA-approved for psychiatric treatment?

Ketamine itself is not FDA-approved for psychiatric disorders. Certain ketamine-related treatments, such as esketamine, have specific FDA-approved indications and safety requirements.

Can therapists administer ketamine?

Medication administration depends on professional scope of practice, applicable laws, and the treatment setting. Therapists should not assume that psychotherapy credentials authorize medication administration.

What should clinicians learn before entering this field?

Training should cover patient preparation, psychotherapy, safety, screening, integration, ethics, collaboration, and the current evidence.

Is ketamine-assisted psychotherapy well established?

It is an emerging area of practice. Research is growing, but studies remain varied, and more high-quality trials are needed to establish standardized approaches.

Why is patient screening important?

Screening helps clinicians identify relevant medical, psychiatric, medication-related, and safety considerations before treatment begins.

Does ketamine replace traditional psychotherapy?

No. Ketamine-based approaches are generally considered within a broader treatment plan rather than as a universal replacement for established psychotherapy methods.

The Bottom Line

Ketamine-related care may give clinicians another area in which to develop their knowledge and broaden conversations about treatment options. However, responsible practice requires more than familiarity with the medication. It calls for appropriate training, careful patient selection, clear professional roles, and an understanding of current evidence.

The Ko-Op reflects the broader movement toward clinician education in emerging therapeutic approaches. As research continues to develop, clinicians can approach this field with curiosity while keeping patient safety, ethical practice, and sound clinical judgment at the forefront.